Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 27 12 2020
accepted: 28 04 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 28 10 2021
Statut: epublish

Résumé

To assess the prevalence of isolated teratozoospermia (iTZS) in a cohort of infertile and fertile men; explore the relationship between iTZS, inflammatory parameters and sperm DNA fragmentation index (SDF) in the same cohort. 1824 infertile men and 103 fertile controls. Semen analysis, the neutrophil-to-lymphocyte ratio (NLR) and serum hormones were investigated. DFI was tested in infertile men only. According to 2010 WHO semen analysis, patients were categorized in 3 sub-groups of isolated sperm defects: isolated oligozoospermia (iOZS), isolated asthenozoospermia (iAZS) and iTZS. Descriptive statistics and linear regression models tested the association between clinical variables and inflammatory markers. Among infertile men, iAZS, iTZS, and iOZS were found in 13.9%, 11.9% and 4.1% participants, respectively. iTZS was found in 37 (35.9%) fertile men. Infertile men with iTZS had higher NLR values than those with iOZS, iAZS and men with normal semen parameters (all p<0.001). FSH and LH were higher and inhibin B lower in iOZS infertile men compared to all other groups (p≤0.001). Hormonal characteristics were similar between iTZS infertile and fertile men. Similarly, iTZS infertile men had higher SDF than all other groups (all p<0.001). Infertile men with iTZS had higher NLR values than fertile men with iTZS (p<0.01). Linear regression analysis showed that, in infertile men, iTZS was associated with SDF and NLR (all p≤0.01). iTZS was found in 11.9% of infertile men but it was even more prevalent in fertile controls. Infertile men with iTZS had higher NLR than fertile controls and increased SDF values than infertile participant with iAZS, iOZS, or normal semen parameters. No differences in hormonal characteristics were found between infertile and fertile men with iTZS.

Identifiants

pubmed: 34097690
doi: 10.1371/journal.pone.0251608
pii: PONE-D-20-40686
pmc: PMC8184012
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0251608

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Andrologia. 2019 Jun;51(5):e13252
pubmed: 30821000
Hum Reprod Update. 2010 May-Jun;16(3):231-45
pubmed: 19934213
Urology. 2002 Dec;60(6):1069-72
pubmed: 12475672
Nat Rev Urol. 2017 Aug;14(8):470-485
pubmed: 28508879
Environ Sci Pollut Res Int. 2018 May;25(14):13775-13786
pubmed: 29508198
J Urol. 2019 Oct;202(4):801-805
pubmed: 31009287
Asian J Androl. 2012 Jul;14(4):584-90
pubmed: 22522503
Andrology. 2020 Sep;8(5):1095-1106
pubmed: 32096605
Cureus. 2019 Jul 25;11(7):e5242
pubmed: 31565640
Andrologia. 2021 Feb;53(1):e13861
pubmed: 33125742
Int J Prev Med. 2012 Jun;3(6):428-31
pubmed: 22783470
N Engl J Med. 2001 Nov 8;345(19):1388-93
pubmed: 11794171
BMC Res Notes. 2017 Jan 3;10(1):12
pubmed: 28057051
Parasitology. 2014 Sep;141(11):1489-98
pubmed: 24721985
Mol Med Rep. 2018 Aug;18(2):1297-1304
pubmed: 29901159
J Assist Reprod Genet. 2010 Jan;27(1):3-12
pubmed: 20012685
Mol Hum Reprod. 2013 Aug;19(8):475-85
pubmed: 23548339
Reprod Biol Endocrinol. 2018 Mar 14;16(1):23
pubmed: 29540184
World J Mens Health. 2017 Apr;35(1):51-56
pubmed: 28459146
Asian J Androl. 2017 Jan-Feb;19(1):39-42
pubmed: 27751992
Cell Mol Life Sci. 2020 Jan;77(1):93-113
pubmed: 31377843
Arab J Urol. 2018 Feb 01;16(1):87-95
pubmed: 29713539
Int Arch Med. 2012 Jan 26;5(1):2
pubmed: 22281066
J Assist Reprod Genet. 2014 May;31(5):527-32
pubmed: 24566945
Curr Urol Rep. 2019 Jun 15;20(8):43
pubmed: 31203470
Front Physiol. 2018 Feb 20;9:113
pubmed: 29515456
Eur Urol. 2016 Dec;70(6):920-923
pubmed: 27343001
Andrology. 2018 Jul;6(4):559-563
pubmed: 29611369
Reprod Med Biol. 2019 Sep 03;18(4):390-396
pubmed: 31607800
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Rev Reprod. 1999 Jan;4(1):31-7
pubmed: 10051100
J Assist Reprod Genet. 2011 Jan;28(1):41-8
pubmed: 20872065
CMAJ. 2006 Aug 29;175(5):495-500
pubmed: 16940270
Regen Biomater. 2017 Feb;4(1):55-68
pubmed: 28149530
Hum Exp Toxicol. 2018 Mar;37(3):247-255
pubmed: 28413887
J Assist Reprod Genet. 2015 Apr;32(4):615-23
pubmed: 25711835
Bratisl Lek Listy. 2001;102(1):5-14
pubmed: 11723675
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32583849
Urology. 2009 Oct;74(4):789-93
pubmed: 19643462
Fertil Steril. 2011 Mar 1;95(3):1141-5
pubmed: 21030014
Andrologia. 1977 Apr-Jun;9(2):191-2
pubmed: 70178
Mol Med. 2015 Jan 30;21:109-22
pubmed: 25786204
Hum Reprod Update. 2017 Nov 1;23(6):646-659
pubmed: 28981654
Hum Reprod. 1997 May;12(5):1015-20
pubmed: 9194657
J Androl. 2002 Jan-Feb;23(1):25-43
pubmed: 11780920
J Reprod Infertil. 2015 Jul-Sep;16(3):123-9
pubmed: 26913230
Asian J Androl. 2020 Jul-Aug;22(4):348-353
pubmed: 31571640
Hum Reprod. 2007 May;22(5):1413-9
pubmed: 17303629
Genet Test Mol Biomarkers. 2020 Apr;24(4):195-203
pubmed: 32208936
World J Mens Health. 2019 Sep;37(3):347-354
pubmed: 30799563
Andrologia. 2018 Dec;50(11):e13126
pubmed: 30569652
Reprod Biol Endocrinol. 2014 May 27;12:45
pubmed: 24884815
Int Braz J Urol. 2007 Sep-Oct;33(5):603-21
pubmed: 17980058
Hum Reprod. 2019 Feb 1;34(2):209-217
pubmed: 30517657
Asian J Androl. 2011 Jan;13(1):59-68
pubmed: 21076438

Auteurs

Luigi Candela (L)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Luca Boeri (L)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Department of Urology, Foundation IRCCS Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Paolo Capogrosso (P)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Department of Urology and Andrology, Ospedale di Circolo and Macchi Foundation,Varese, Italy.

Walter Cazzaniga (W)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Edoardo Pozzi (E)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Federico Belladelli (F)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Andrea Baudo (A)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Andrea Ravizzoli (A)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Eugenio Ventimiglia (E)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

Paola Viganò (P)

Obstetrics and Gynaecology Department, IRCCS Ospedale San Raffaele, Milan, Italy.
Division of Genetics and Cell Biology, Reproductive Sciences Laboratory, IRCCS Ospedale San Raffaele, Milan, Italy.

Massimo Alfano (M)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

Costantino Abbate (C)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

Julian Cornelius (J)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Agostino Mattei (A)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Francesco Montorsi (F)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Andrea Salonia (A)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH